Related Experiment Video
Updated: Apr 30, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go?
Björn Meijers1, Griet Glorieux2, Ruben Poesen1
1Department of Nephrology, University Hospitals Leuven, Leuven, Belgium; Department of Immunology and Microbiology, KU Leuven, Leuven, Belgium.
The gut-kidney axis impacts kidney disease by influencing uremic toxins from diet and gut microbes. This review explores dietary and non-dialysis therapies for chronic kidney disease patients.
Area of Science:
- Nephrology
- Gastroenterology
- Microbiology
Background:
- Uremic milieu arises from imbalanced retention solutes and kidney function.
- Intestinal tract is a key source of uremic retention solutes via diet and microbial metabolism.
- The gut-kidney axis describes the intestinal-kidney interaction.
Purpose of the Study:
- To review current knowledge of the gut-kidney axis.
- To explore therapeutic interventions for chronic kidney disease (CKD) patients.
Main Methods:
- Literature review of the gut-kidney axis.
- Analysis of dietary and non-extracorporeal interventions in CKD.
Main Results:
- The gut-kidney axis significantly contributes to uremic toxin accumulation.
- Diet and gut microbiota are crucial modulators of the gut-kidney axis.
- Non-dialysis interventions show potential in managing CKD.
Conclusions:
- Understanding the gut-kidney axis is vital for CKD management.
- Dietary and microbial interventions offer promising therapeutic avenues.
- Further research into non-extracorporeal therapies is warranted for CKD.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Drug Elimination by Renal Route: Tubular Secretion
Drug Elimination by Renal Route: Tubular Reabsorption

